Folfiri vs xeliri in untreated advanced colorectal cancer: A phase II randomised trial of the gruppo oncologico dell'italia meridionale (Prot. Goim 2405)

被引：0
|
作者：
Colucci, G. [2 ]
Giuliani, F. [2 ]
De Vita, F. [1 ]
Di Bisceglie, M. [2 ]
Maiello, E. [3 ]
Romito, S. [2 ]
Caruso, M.
Catalano, G. [1 ]
机构：
[1] Univ Naples 2, Med Oncol Unit, Naples, Italy
[2] NCI, Dept Med Oncol, Bari, Italy
[3] Cardarelli Hosp, Med Oncol Unit, Campobasso, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [41] A Multicenter Phase II Randomized Trial of Docetaxel/Gemcitabine versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Gruppo Oncologico Italia Meridionale Study
    Vici, P.
    Giotta, F.
    Di Lauro, L.
    Sergi, D.
    Vizza, E.
    Mariani, L.
    Latorre, A.
    Pizzuti, L.
    D'Amico, C.
    Giannarelli, D.
    Colucci, G.
    ONCOLOGY, 2011, 81 (3-4) : 230 - 236
  • [42] Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale
    Galetta, D
    Gebbia, V
    Giotta, F
    Durini, E
    Romito, S
    Borsellino, N
    Cazzato, C
    Pezzella, G
    Colucci, G
    LUNG CANCER, 2002, 38 (01) : 79 - 84
  • [43] ACTIVITY AND TOLERABILITY OF CISPLATIN (CDDP) AND FOTEMUSTINE (FTM) COMBINATION IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) WITH BRAIN METASTASES (BM): A MULTICENTRIC PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM)
    Galetta, D.
    Gebbia, V.
    Romito, S.
    Ferrau, E.
    De Marinis, F.
    Cigolari, S.
    Adamo, S.
    Colucci, G.
    EJC SUPPLEMENTS, 2008, 6 (14): : 151 - 151
  • [44] Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
    De Vita, F.
    Giuliani, F.
    Orditura, M.
    Maiello, E.
    Galizia, G.
    Di Martino, N.
    Montemurro, F.
    Carteni, G.
    Manzione, L.
    Romito, S.
    Gebbia, V.
    Ciardiello, F.
    Catalano, G.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2007, 18 (08) : 1354 - 1358
  • [45] Cisplatin (P) Combined with Docetaxel (T) or Vinorelbine (V) as Front-Liner Therapy in Patients with Advanced Non-Small Cell Lung Cancer: A Randomised Phase II Trial of the Gruppo Oncologico Italia Meridionale
    Gebbia, V.
    Lorusso, V.
    Galetta, D.
    Caruso, M.
    Maiello, E.
    Riccardi, F.
    Carrozza, F.
    Borsellino, N.
    Leo, S.
    Ferrau, F.
    Cinieri, S.
    Colucci, G.
    ONCOLOGY, 2009, 77 : 145 - 146
  • [46] Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: A prospective randomized phase III trial of the GOIM (Gruppo Oncologico Italia Meridionale)
    Gebbiaa, Vittorio
    Galetta, Domenico
    Lorusso, Vito
    Caruso, Michele
    Verderame, Francesco
    Pezzella, Giuseppe
    Borsellino, Nicolo
    Durini, Ernesto
    Valenza, Roberto
    Agostara, Biagio
    Colucci, Giuseppe
    LUNG CANCER, 2008, 61 (03) : 369 - 377
  • [47] First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale
    Gebbia, Vittorio
    Lorusso, Vito
    Galetta, Domenico
    Caruso, Michele M.
    Palomba, Giuseppe
    Riccardi, Fernando
    Borsellino, Nicolo
    Carrozza, Francesco
    Leo, Silvana
    Ferrau, Francesco
    Cinieri, Saverio
    Mancuso, Gianfranco
    Mancarella, Sergio
    Colucci, Giuseppe
    LUNG CANCER, 2010, 69 (02) : 218 - 224
  • [48] First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small cell lung cancer: A randomized phase II trial of the Gruppo Oncologico Italia Meridionale
    Gebbia, V.
    Galetta, D.
    Lorusso, V.
    Caruso, M.
    Riccardi, F.
    Maiello, E.
    Borsellino, N.
    Ferrau, F.
    Colucci, G.
    Cinieri, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)
    Galetta, D.
    Gebbia, V.
    Silvestris, N.
    Ferrau, F.
    Carrozza, F.
    Cigolari, S.
    Russo, P.
    Calista, F.
    Adamo, V.
    Colucci, G.
    LUNG CANCER, 2011, 72 (01) : 59 - 63
  • [50] FIRST-LINE CISPLATIN (P) WITH DOCETAXEL (TXT) OR VINORELBINE (VNR) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER: A PHASE II RANDOMIZED TRIAL OF GRUPPO ONCOLOGICO ITALIA MERIDIONALE
    Gebbia, V.
    Lorusso, V.
    Galetta, D.
    Caruso, M.
    Maiello, E.
    Riccardi, F.
    Carrozza, F.
    Borsellino, N.
    Leo, S.
    Ferrau, F.
    Cinieri, S.
    Colucci, G.
    EJC SUPPLEMENTS, 2008, 6 (14): : 151 - 151
12345